Ontology highlight
ABSTRACT:
SUBMITTER: Yu M
PROVIDER: S-EPMC7192976 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
Yu Miao M Yuan Guo Yue GY Zhang Bin B Wu Hai Ya HY Lv Xiao Feng XF
Diabetes therapy : research, treatment and education of diabetes and related disorders 20200410 5
<h4>Introduction</h4>To evaluate the efficacy and safety of dulaglutide 0.75 and 1.5 mg in patients with type 2 diabetes mellitus (T2DM) by baseline glycated hemoglobin (HbA1c) < 8.5% or ≥ 8.5% after 26 weeks of treatment.<h4>Methods</h4>Assessment of the Weekly AdministRation of dulaglutide in Diabetes (AWARD) China 1 (CHN1) study (NCT01644500, n = 556) included patients on dulaglutide vs. glimepiride who were treatment naïve or on monotherapy but discontinued therapy. AWARD-CHN2 (NCT01648582, ...[more]